STOCK TITAN

If You Invested in BlackRock Health Sciences Trust (BME)

Financial Services · Asset Management · NYSE
Looking for the live price? See the BME quote & overview
$1,000 invested 1 Year Ago
$1,201
+20.1% total 20.2% CAGR
Bought on Jul 7, 2025 at $36.26
$1,000 invested 5 Years Ago
$888
-11.2% total -2.3% CAGR
Bought on Jul 7, 2021 at $49.02

What $1,000 or $10,000 in BME Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 8, 2015
$1,000 $1,201 +20% $888 -11% $1,213 +21% $1,035 +3%
$10,000 $12,010 +20% $8,884 -11% $12,134 +21% $10,347 +3%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for BME

$1,000 Investment Over Time

BME vs S&P 500

Year-by-Year Returns

BME annual performance
Year Start Price End Price Annual Return Cumulative
2017 $32.35 $36.50 +12.8% +12.8%
2018 $36.44 $36.45 +0.0% +12.7%
2019 $37.63 $42.50 +12.9% +31.4%
2020 $42.89 $47.59 +11.0% +47.1%
2021 $48.39 $48.50 +0.2% +49.9%
2022 $48.09 $43.58 -9.4% +34.7%
2023 $43.42 $40.46 -6.8% +25.1%
2024 $40.60 $37.93 -6.6% +17.2%
2025 $37.49 $41.13 +9.7% +27.1%
2026 $41.19 $43.55 +5.7% +34.6%

About BlackRock Health Sciences Trust

Financial Services · NYSE

Blackrock Health Sciences Trust (BME) is a closed-end investment fund focused on the finance and insurance sector, within the securities and commodity exchanges industry. According to its stated investment objective, the trust seeks to provide total return through a combination of current income, current gains, and long-term capital appreciation. It does this by investing primarily in equity securities of companies engaged in health sciences and related industries, as well as in equity derivatives.

The trust’s strategy, as described in available information, is to invest at least 80% of its total assets in equity securities of health sciences companies and related industries and in equity derivatives. This focus on health sciences means the portfolio is concentrated in businesses connected to healthcare and related fields, while the use of equity derivatives is intended to support the objective of generating current income, gains, and capital appreciation over time.

Investment Objective and Strategy

The core objective of Blackrock Health Sciences Trust is to generate a total return that combines:

  • Current income
  • Current gains
  • Long-term capital appreciation

To pursue this objective, the fund states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This approach aligns the trust with the performance and developments of the health sciences space, while also allowing it to use derivatives linked to equity markets as part of its strategy.

Sector and Industry Classification

For classification purposes on Stock Titan, Blackrock Health Sciences Trust is associated with the Finance and Insurance sector and the Securities and Commodity Exchanges industry. This reflects its structure as an investment vehicle whose shares trade in public markets and whose primary activity is investing in securities rather than producing or selling health-related products or services directly.

Health Sciences Focus

The trust’s emphasis on companies engaged in health sciences and related industries means its portfolio is tied to businesses operating in or around the broader healthcare ecosystem. While specific holdings are not detailed in the provided information, the mandate clearly links the fund’s investments to equity securities in that area and to equity derivatives connected to those markets.

Use of Equity Derivatives

Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These instruments are used as part of the trust’s effort to achieve its stated objectives of current income, current gains, and long-term capital appreciation. The exact types of derivatives or strategies are not specified in the provided data, but their inclusion is a defined part of the investment approach.

Relationship to BlackRock

The trust carries the Blackrock name, indicating association with the broader BlackRock fund family. Separate news items describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology that helps people build savings by making investing easier and more affordable. However, the news materials focus on BlackRock at the corporate level and on other products and platforms, not on BME specifically, so they are best understood as general context about the sponsor brand rather than detailed information about this particular trust.

Trading and Investor Considerations

As an investment fund classified in the securities and commodity exchanges industry, Blackrock Health Sciences Trust is designed for investors who want exposure to health sciences and related industries through a professionally managed, exchange-traded vehicle. The fund’s objective and 80% investment policy are central reference points for understanding how it is intended to operate. Specific details such as current portfolio composition, distribution policy, or leverage, if any, are not provided in the available data and would need to be obtained from official fund documents.

Evergreen Characteristics

The elements that define Blackrock Health Sciences Trust in a durable way are its:

  • Stated objective of total return through current income, current gains, and long-term capital appreciation
  • Policy to invest 80% of total assets in equity securities of health sciences and related industries and in equity derivatives
  • Placement in the finance and insurance sector and securities and commodity exchanges industry

These characteristics describe the structural design of the trust rather than short-term performance or time-sensitive details, making them useful for long-term reference when researching the BME stock.

Market Cap
$0.6B
Current Price
$43.55
View full BME overview

Frequently Asked Questions

BlackRock Health Sciences Trust investment returns

How much would $1,000 invested in BlackRock Health Sciences Trust be worth today?

If you invested $1,000 in BlackRock Health Sciences Trust (BME) 10 years ago on 2016-07-07, your investment would be worth $1,213 today, representing a +21.3% total return, growing at a compounded rate of 2.0% per year (CAGR).

Has BlackRock Health Sciences Trust outperformed the S&P 500?

Over the past 10 years, BME returned +21.3% compared to +258.6% for the S&P 500, underperforming the benchmark by 237.2 percentage points.

What is BlackRock Health Sciences Trust's average annual return?

The compound annual growth rate (CAGR) of BME over the past 10 years is 2.0%, growing at a compounded rate each year. Individual years vary significantly — BME's best recent year was 2019 (+12.9%) and worst was 2022 (-9.4%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.